Bullish Combo Goes Up in MYGN
Shares of Myriad Genetics (MYGN) are up .16 to 27.01. MYGN is trading at the lower end of the 52-week range.
Today paper bought 3300 MYGN Oct 30 calls for .65 and sold 1650 Oct 24 puts at .45. The ADV is 2,646 contracts. The OI is 219 and 39 contracts.
The volume went up as a two block trading through the call offer and hitting the bid at the time. I did not see a stock print go up but the calls did trade .05 through the posted offer for the size. Without stock this would be a very bullish upside risk reversal.
30-day implied volatility is 48%. 10-day implied volatility is 48%. 30-day implied volatility is trading at the 10-day historical volatility.
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests.
View The Options Insider's post archive >